These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 17307970)

  • 1. Overview of PDEs and their regulation.
    Omori K; Kotera J
    Circ Res; 2007 Feb; 100(3):309-27. PubMed ID: 17307970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterases in the central nervous system.
    Kleppisch T
    Handb Exp Pharmacol; 2009; (191):71-92. PubMed ID: 19089326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM; Brenna KJ; Colman RW; Sheth SB
    Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation.
    Lugnier C; Komas N
    Eur Heart J; 1993 Nov; 14 Suppl I():141-8. PubMed ID: 8293765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
    Cheng J; Grande JP
    Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential function of phosphodiesterase families in the brain: gaining insights through the use of genetically modified animals.
    Kelly MP; Brandon NJ
    Prog Brain Res; 2009; 179():67-73. PubMed ID: 20302819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterases in the central nervous system: implications in mood and cognitive disorders.
    Xu Y; Zhang HT; O'Donnell JM
    Handb Exp Pharmacol; 2011; (204):447-85. PubMed ID: 21695652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian sperm phosphodiesterases and their involvement in receptor-mediated cell signaling important for capacitation.
    Baxendale RW; Fraser LR
    Mol Reprod Dev; 2005 Aug; 71(4):495-508. PubMed ID: 15856425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
    Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
    Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyclic nucleotide phosphodiesterase IV expression, activity and targeting in cells of cardiovascular system].
    Yan J; Zhu HB
    Yao Xue Xue Bao; 2007 Jun; 42(6):571-5. PubMed ID: 17702390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic regulation of cAMP signaling by cGMP in the cardiovascular system: roles of phosphodiesterase 2 and phosphodiesterase 3 enzymes.
    Maurice DH
    Proc West Pharmacol Soc; 2003; 46():32-6. PubMed ID: 14699879
    [No Abstract]   [Full Text] [Related]  

  • 13. Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2016 Feb; 91():215-27. PubMed ID: 26773602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotide specific phosphodiesterases of Leishmania major.
    Johner A; Kunz S; Linder M; Shakur Y; Seebeck T
    BMC Microbiol; 2006 Mar; 6():25. PubMed ID: 16522215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
    Rybalkin SD; Bornfeldt KE
    Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclic nucleotide phosphodiesterases and vascular smooth muscle.
    Polson JB; Strada SJ
    Annu Rev Pharmacol Toxicol; 1996; 36():403-27. PubMed ID: 8725396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.
    Lugnier C
    Pharmacol Ther; 2006 Mar; 109(3):366-98. PubMed ID: 16102838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions.
    Francis SH; Blount MA; Corbin JD
    Physiol Rev; 2011 Apr; 91(2):651-90. PubMed ID: 21527734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling human phosphodiesterase genes and splice isoforms.
    Bingham J; Sudarsanam S; Srinivasan S
    Biochem Biophys Res Commun; 2006 Nov; 350(1):25-32. PubMed ID: 16987497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10).
    McCahill A; Campbell L; McSorley T; Sood A; Lynch MJ; Li X; Yan C; Baillie GS; Houslay MD
    Cell Signal; 2008 Nov; 20(11):2071-83. PubMed ID: 18721873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.